本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Revolution Medicines, Inc.

53.49
-0.5200-0.96%
盤後53.490.00000.00%19:44 EDT
成交量:160.59萬
成交額:8,689.10萬
市值:99.99億
市盈率:-11.82
高:55.20
開:54.76
低:53.17
收:54.01
52周最高:62.40
52周最低:29.17
股本:1.87億
流通股本:1.59億
量比:0.62
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
淨資產收益率:-46.61%
總資產收益率:-26.47%
市淨率:5.36
市盈率(LYR):-14.95

資料載入中...

2024/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities